In 2015 Ron was diagnosed with stage 4 colorectal cancer. He received traditional, but debilitating, chemotherapy treatment for 9 months.

He wasn’t able to eat or sleep, and his devastated wife, Maria, searched for other options. In 2016, after learning he carried a genetic mutation linked to Lynch syndrome, Ron began a nivolumab/ipilimumab combination immunotherapy on a clinical trial at University of Pittsburgh Medical Center. Today, Ron continues to receive nivo/ipi as part of routine care and, for the past 2 years, has had no evidence of disease progression. “I am able to live on immunotherapy,” Ron explained.

This video is presented as part of the Cancer Research Institute 6th Annual Cancer Immunotherapy Month awareness campaign this June 2018. Learn more about cancer immunotherapy and its potential to save more lives at

Leave a Reply

Let us help fight cancer. Share your knowledge.


Latest news, views, insights and trends on cancer treatment, discovery and support